4Chang A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC [J]. Lung cancer, 2011,71(1) :3-10.
5Hontscha C, Borck Y, Zhou H, et al. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC) [J]. J Cancer Res Clin Oncol, 2010,137(2) :305-310.
6Schmidt-Wolf I, Negrin RS, Kiem HP, et al. Use of a SCID mouse/ human lymphoma model to evaluate cytokine-induced killer cellswith potent antitumor cell activity [J]. J Exp Med, 1991, 174( 1 ) : 139-149.
7Blattman JN, Greenberg PD. Cancer immunotherapy: a treatment for the masses [J]. Science, 2004,305(5681 ) :200-205.
8Li H, Wang C, Yu J, et al. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chem-otherapy on non-small cell lung cancer in patients after surgery [ J]. Cytothera- py, 2009,11(8) :1076-1083.
